Promore Pharma AB (publ) announced that at its extraordinary general meeting held on 29 December 2023, approved the election of Magnus Christensen, Christer Ahlberg, Anne Dorney and Myles Murray as directors and Peter Donnelly as director and Chairman of the Board, for the period until the end of the next Annual General Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.15 SEK | -1.21% | -4.68% | -26.92% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.92% | 1.59Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- PMDS Stock
- News PMD Device Solutions AB
- Promore Pharma AB Announces Board Appointments